Under federal law, the definition of a controlled substance is any drug, other substance, or immediate precursor that appears on Schedule I, II, III, IV, or V of the Controlled Substances Act. That language comes from 21 U.S.C. § 802(6) and has stood essentially unchanged since 1970.121 U.S.C. § 802(6) The label matters because it pulls a substance into a full regulatory system: who can make it, prescribe it, dispense it, possess it, and what happens to anyone who steps outside those rules.
The definition is deliberately wide. It reaches finished pharmaceuticals, raw plant material, synthetic compounds, and the chemical building blocks used to produce them. “Immediate precursor” has its own statutory meaning under 21 U.S.C. § 802(23): a substance the Attorney General has designated as the principal compound used to manufacture a controlled drug, that acts as a direct chemical intermediary, and whose control is necessary to limit production of the finished product. Regulating precursors lets the government intervene before a drug is ever made.
What Is Not a Controlled Substance
Three categories sit outside the definition even though people often assume they are inside it.
Distilled spirits, wine, malt beverages, and tobacco are expressly excluded. They are regulated through the Internal Revenue Code rather than the Controlled Substances Act, so drug trafficking penalties never apply to their commercial sale, regardless of the dependence and health risks involved.
Hemp is also excluded. The 2018 Farm Bill amended the federal definition of “marihuana” in 21 U.S.C. § 802(16) to carve out hemp, meaning cannabis containing no more than 0.3 percent THC by dry weight. Cannabis above that threshold stays controlled. Hemp-derived products, including many CBD oils, are legal to possess under federal law, though the FDA has concluded that existing food and supplement rules are not appropriate for CBD products and continues to issue warning letters to companies selling CBD-infused food and beverages.
The Five Schedules
Every controlled drug sits in one of five schedules. Placement turns on three broad questions: how likely the substance is to be abused, whether it has an accepted medical use in the United States, and how likely it is to cause physical or psychological dependence. Schedule I is the most restrictive, and restrictions generally loosen as the number climbs.
- Schedule I: high abuse potential, no accepted medical use, and no accepted safety for use even under medical supervision. Heroin, LSD, and most forms of marijuana currently fall here.
- Schedule II: high abuse potential, but with an accepted medical use that may carry severe restrictions. Abuse can lead to severe dependence. Fentanyl, oxycodone, and methamphetamine are in this category.
- Schedule III: lower abuse potential than Schedules I and II, accepted medical use, moderate physical or high psychological dependence risk. Anabolic steroids and ketamine are examples.
- Schedule IV: low abuse potential relative to Schedule III, accepted medical use, limited dependence risk. Benzodiazepines like alprazolam and sleep aids like zolpidem fall here.
- Schedule V: the lowest abuse potential of any scheduled substance, accepted medical use, limited dependence risk. Cough preparations with small amounts of codeine are a common example.
Everything from Schedule II through Schedule V must have a currently accepted medical use. That is what sets Schedule I apart: a drug cannot leave Schedule I until the government recognizes a legitimate medical application for it. The schedule also controls how a drug can be prescribed. Schedule I substances cannot be prescribed at all; they are available only for approved research. Schedule II drugs cannot be refilled. Schedules III and IV allow up to five refills within six months of the original prescription. Schedule V substances are sometimes available without a prescription in limited quantities, depending on state law.
How a Substance Gets Scheduled
Adding, moving, or removing a substance is not a judgment call. Federal law lays out eight factors under 21 U.S.C. § 811(c) that the government must weigh:
- Actual or relative potential for abuse compared with drugs already scheduled.
- Pharmacological effects, based on scientific evidence of how the drug acts on the body.
- The current state of scientific knowledge about the substance.
- History and current pattern of abuse.
- Scope, duration, and significance of that abuse.
- Risk to public health beyond individual users.
- Dependence liability, physical or psychological.
- Whether the substance is an immediate precursor of something already controlled.
Scheduling authority is split between the Drug Enforcement Administration and the Department of Health and Human Services. Either agency can begin the process, and outside parties can petition for changes. Before any decision becomes final, the Attorney General must request a scientific and medical evaluation from the Secretary of Health and Human Services, which in practice means the FDA conducts the assessment. The Secretary’s recommendations on scientific and medical questions are binding on the DEA. If HHS concludes a substance has no potential for abuse, the DEA cannot schedule it.
Emergency Scheduling
When a new substance presents an immediate public safety threat and the normal process would take too long, the Attorney General can temporarily place it on Schedule I under 21 U.S.C. § 811(h). The emergency finding requires an imminent hazard to public safety and considers only three of the eight factors: abuse history, risk to public health, and evidence of clandestine manufacturing or diversion. The DEA must publish a 30-day notice before the temporary order takes effect. A temporary order lasts two years, with a one-year extension available if permanent scheduling proceedings are underway, and these orders are not subject to judicial review. The emergency power has been used repeatedly in recent years to address waves of synthetic drugs and fentanyl analogues that appear on the market faster than the standard process can keep up.
Designer Drugs and the Analogue Act
Chemists sometimes design compounds that mimic a scheduled drug’s effects but have slightly different molecular structures, which would otherwise put them outside the official schedules. The Federal Analogue Act, 21 U.S.C. § 813, closes that gap. A substance with a chemical structure substantially similar to a Schedule I or II drug is treated as a Schedule I controlled substance when it is intended for human consumption.
Intent is where these cases turn. Courts look at how the substance was marketed and labeled, whether its price matched its claimed non-drug purpose, and whether it moved through clandestine channels. Labeling a product “not for human consumption” is not, by itself, a defense. In McFadden v. United States (2015), the Supreme Court held that the government must show either that the defendant knew the substance was regulated under the Controlled Substances Act or that the defendant knew its specific chemical identity.
Marijuana’s Split Classification
Marijuana’s federal status is more complicated than a single schedule number can capture. As of 2026, most marijuana remains a Schedule I controlled substance. A final rule published in April 2026 moved two specific categories to Schedule III: FDA-approved drug products containing THC derived from cannabis, and marijuana held under a state medical marijuana license. Unlicensed bulk marijuana, recreational marijuana, and cannabis outside an FDA approval or state medical license stay on Schedule I.
A patient using marijuana under a valid state medical license is dealing with a Schedule III substance under federal law. Someone possessing the same plant without that license still faces Schedule I consequences. The rescheduling does not legalize recreational marijuana at the federal level, and unlicensed marijuana remains subject to the full range of Schedule I enforcement.
Who Can Legally Handle a Controlled Substance
Anyone who manufactures, distributes, dispenses, or prescribes controlled substances must hold a valid DEA registration. Doctors, pharmacists, hospitals, researchers, and manufacturers each register using specific DEA forms, and applications and renewals are submitted online. Operating under an expired registration is illegal from day one, though the DEA allows reinstatement within one calendar month after expiration. Miss that window and a fresh application is required. Ordering Schedule I and II substances requires a DEA Form 222 or its electronic equivalent through the Controlled Substance Ordering System, which creates an auditable paper trail reflecting the higher abuse potential of those drugs.
Federal Penalties
Penalties depend on the schedule, the quantity, and whether anyone was harmed.
Distribution
For distribution of Schedule I or II substances, penalties scale with statutory quantity thresholds. At the highest tier, a first offense carries a mandatory minimum of 10 years and a maximum of life. If death or serious bodily injury results from use of the substance, the minimum rises to 20 years. A second serious drug felony pushes the minimum to 15 years; a third can mean at least 25 years. For smaller quantities without aggravating factors, a first offense can carry up to 20 years, with a 30-year maximum for repeat offenders. Lower-schedule distribution carries shorter sentences, and a first Schedule IV offense is capped at 5 years.
Simple Possession
A first offense for simple possession of any controlled substance carries up to one year in prison and a minimum fine of $1,000. A second offense raises the range to 15 days to 2 years with a $2,500 minimum fine. After two or more prior drug convictions, the penalty becomes 90 days to 3 years with a $5,000 minimum fine. These minimum sentences cannot be suspended or deferred.
State Schedules Are Not Always the Same
Federal schedules are not the final word. Every state keeps its own controlled substance schedules, and they do not always match the federal lists. States can schedule substances the federal government has not touched, as several did with xylazine and certain fentanyl analogues before the DEA acted. States can also decline to adopt federal scheduling decisions, or simply lag behind because state legislation takes time.
The practical result: a substance may be legal federally but controlled in your state, or the reverse. The gap is clearest with marijuana, where many states have legalized medical or recreational use even as most forms remain federally Schedule I. Any controlled substance question should be checked against both the federal schedules and the schedules of the state where the activity takes place.